Insulet Corporation’s PODD rapid commercial expansion and increasing market access capabilities for its Omnipod platform are ...

Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

So, that is the burden that Civilization 7 carries with it. Here is a game that, after playing through the first of its three distinct eras, is shaping up to be very good, but the fact that it’s ...

tubeless Omnipod 5 automated insulin delivery (“AID”) system for more people. Following the announcement on Jan. 14, PODD’s shares climbed 0.7% to $270 at yesterday’s after-market trading ...

The latest development represents a significant step forward in expanding access to its innovative, tubeless Omnipod 5 automated insulin delivery (“AID”) system for more people. Following the ...